ArticleResearch and practice in thrombosis and haemostasis2026
Safety, tolerability, pharmacokinetics, and pharmacodynamics of KN060, a humanized anti-FXI/FXIa dual-domain antibody, following single ascending doses in healthy Chinese subjects.
Jie Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.